Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Aclazid-250 Clarithromycin Tablets 250 mg
Aclazid-250 Clarithromycin Tablets contain 250 mg of clarithromycin, a broad-spectrum macrolide antibiotic. This medication is employed in treating various bacterial infections by inhibiting the growth of bacteria, thus facilitating the bodys natural healing processes.
Uses of Aclazid-250 Clarithromycin Tablets 250 mg
Respiratory Tract Infections: Treats infections such as pneumonia, bronchitis, and sinusitis.
Skin and Soft Tissue Infections: Effective against skin infections, including cellulitis and impetigo.
Gastrointestinal Infections: Used to address certain gastrointestinal infections caused by Helicobacter pylori.
Other Bacterial Infections: Effective against a range of other bacterial infections as determined by sensitivity tests.
Benefits of Aclazid-250 Clarithromycin Tablets 250 mg
Broad-Spectrum Activity: Targets a wide range of bacteria, making it effective for various infections.
High Efficacy: Demonstrated effectiveness in treating both gram-positive and some gram-negative bacteria.
Convenient Dosing: Available in a 250 mg dose that simplifies the dosing regimen.
Good Tolerability: Generally well-tolerated with a favorable safety profile.
Mechanism of Action of Aclazid-250 Clarithromycin Tablets 250 mg
Clarithromycin, the active ingredient in Aclazid-250, functions by inhibiting bacterial protein synthesis. It binds to the 50S ribosomal subunit of bacterial ribosomes, obstructing the translocation of peptides during protein synthesis. This action prevents bacteria from growing and reproducing, leading to their elimination from the body.